ProANP as a screening biomarker for hypertrophic cardiomyopathy in Maine coon cats

Journal title

Polish Journal of Veterinary Sciences




No 4


Divisions of PAS

Nauki Biologiczne i Rolnicze


Polish Academy of Sciences Committee of Veterinary Sciences ; University of Warmia and Mazury in Olsztyn




DOI: 10.1515/pjvs-2016-0101 ; ISSN 1505-1773


Polish Journal of Veterinary Sciences; 2016; No 4


MacLean (2006), N - terminal atrial natriuretic peptide immunoreactivity in plasma of cats with hypertrophic cardiomyopathy, J Vet Intern Med, 20, 284, ; Zimmering (2009), Measurement of N - terminal proatrial natriuretic peptide in plasma of cats with and without cardiomyopathy, Am J Vet Res, 70, 216, ; Connolly (2009), Assessment of the diagnostic accuracy of circulating natriuretic peptide concentrations to distinguish between cats with cardiac and non - cardiac causes of respiratory distress Vet, Cardiol, 11, 41. ; Kittleson (1998), Hypertrophic Cardiomyopathy In eds St pp, Small Animal Cardiovascular Medicine, 347. ; Borgeat (2015), Cardiac biomarkers in cats Vet, Cardiol, 17, 74. ; Jarai (2005), Risk assessment in patients with unstable angina / non - ST - elevation myocardial infarction and normal N - terminal pro - brain natriuretic peptide levels by N - terminal pro - atrial natriuretic peptide, Eur Heart J, 26, 250, ; Kołodziejska (2010), Structure , mechanism of action and the significance of natriuretic peptides in the diagnosis of heart disease in dogs, Życie Weterynryjne, 85, 825. ; Lalor (2009), Plasma concentrations of natriuretic peptides in normal cats and normotensive and hypertensive cats with chronic kidney disesase Vet, Cardiol, 11, 71. ; Kittleson (1999), Familial hypertrophic cardiomyopathy in maine coon cats : an animal model of human disease, Circulation, 99, 3172, ; Hall (2003), N - terminal proatrial natriuretic peptide in primary care : relation to echocardiographic indices of cardiac function in mild to moderate cardiac disease, Int J Cardiol, 89, 197, ; Zimmering (2010), Evaluation of the association between plasma concentration of N - terminal proatrial natriuretic peptide and outcome in cats with cardiomyopathy, J Am Vet Med Assoc, 237, 665, ; Connolly (2010), Natriuretic peptides : the feline experience, Vet Clin North Am Small Anim Pract, 40, 559, ; Trehion (2012), Comparative echocardiographic and clinical features of hypertrophic cardiomyopathy in breeds of cats : a retrospective analysis of cases, J Vet Intern Med, 5, 2001. ; Menaut (2012), Circulating natriuretic peptide concentrations in hyperthyroid cats, J Small Anim Pract, 53, 673, ; Meurs (2009), Analysis of sarcomeric candidate genes for feline hypertrophic cardiomyopathy mutations in cats with hypertrophic cardiomyopathy, J Vet Intern Med, 23, 840, ; Boswood (2009), Biomarkers in cardiovascular disease beyond natriuretic peptides Vet, Cardiol, 11, 23. ; Otterstad (2002), St Prognostic value of two - dimensional echocardiography and N - terminal proatrial natriuretic peptide following an acute myocardial infarction, Eur Heart J, 23, 1011, ; Berger (2005), Neurohormonal risk stratification for sudden death and heath owing to progressive heart failure in chronic heart failure, Eur J Clin Invest, 35, 24, ; Jandrey (2012), Thromboembolism : current treatment and future directions, Veterinary Focus, 22, 26, ; Sampedrano (2009), Prospective echocardiographic and tissue Doppler imaging screening of a population of Maine Coon cats tested for the mutation in the myosin - binding protein C gene : a specific analysis of the heterozygous status, J Vet Intern Med, 31, 91, ; Connolly (2008), Circulating natriuretic peptides in cats with heart disease, J Vet Intern Med, 22, 96,